Literature DB >> 2535919

Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.

R Hällgren1, J F Colombel, R Dahl, K Fredens, A Kruse, N O Jacobsen, P Venge, J C Rambaud.   

Abstract

PURPOSE: The concentrations of myeloperoxidase (MPO), a neutrophil granule constituent, and eosinophil cationic protein (ECP), a specific eosinophil granule protein, were measured in jejunal perfusion fluid in an attempt to elucidate the neutrophil and eosinophil involvement of the small bowel in health and disease. PATIENTS AND METHODS: The control group consisted of 14 males and two females. Ten patients (seven males and three females) with Crohn's disease and seven patients (two males and five females) with celiac disease were also studied; in addition, one patient with relapsing giardiasis, one patient with giardiasis and complete absence of plasma cells in small intestinal lamina propria, and one patient with selective IgA deficiency and no IgA plasma cells in duodeno-jejunal lamina propria were evaluated. Segmental perfusion of the jejunum was performed according to a previously described method. MPO and ECP were measured by radioimmunoassays.
RESULTS: In healthy control subjects, the concentrations of both granule proteins were in a narrow range and much higher than would have been anticipated from passive leakage from circulating blood. In patients with celiac disease, the perfusion fluid concentrations of MPO and ECP were on average 3.5 and eight times, respectively, higher than the values seen in the controls. The jejunal segment perfused in patients with Crohn's disease was endoscopically and histologically normal. The perfusion fluid concentrations of MPO and ECP were increased 3.5 and two times, respectively, compared with that in the control subjects. Both patient groups and the control group had similar perfusion fluid concentrations of albumin. Data on MPO and ECP expressed as jejunal secretion rates gave the same differences between patients and controls as just described for the jejunal fluid concentrations. Immunohistochemical studies of jejunal biopsy specimens from another group of patients with celiac disease demonstrated a prominent extracellular deposit of ECP in the lamina propria of the atrophic intestinal mucosa, whereas the release of neutrophil constituents (cathepsin G, MPO) was scarce. In Crohn's disease, an extracellular degranulation of ECP and, to a lesser extent, of cathepsin G was observed in relation to ulcerations only.
CONCLUSION: Data obtained indicate that the local release of neutrophil and eosinophil granule components is enhanced in the jejunal tissue from patients with celiac sprue and Crohn's disease. The prominent extracellular deposit of eosinophil granule constituents with cytotoxic properties at the site of inflammatory intestinal lesions in celiac sprue might reflect a pathophysiologic mechanism.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2535919     DOI: 10.1016/0002-9343(89)90230-1

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  A Commensal Bifidobacterium longum Strain Prevents Gluten-Related Immunopathology in Mice through Expression of a Serine Protease Inhibitor.

Authors:  J L McCarville; J Dong; A Caminero; M Bermudez-Brito; J Jury; J A Murray; S Duboux; M Steinmann; M Delley; M Tangyu; P Langella; A Mercenier; G Bergonzelli; E F Verdu
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

2.  Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11.

Authors:  Amanda Waddell; Richard Ahrens; Kris Steinbrecher; Burke Donovan; Marc E Rothenberg; Ariel Munitz; Simon P Hogan
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

Review 3.  What is the role of the eosinophil?

Authors:  P Venge
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

4.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

5.  Elevated bone marrow eosinophil count is associated with high incidence of severe acute GvHD after allogeneic hematopoietic stem cell transplantation.

Authors:  Y Shimomura; M Hara; H Hashimoto; T Ishikawa
Journal:  Bone Marrow Transplant       Date:  2017-06-19       Impact factor: 5.483

6.  Activated eosinophils in coeliac disease.

Authors:  J F Colombel; A Janin; G Torpier
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

7.  Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.

Authors:  Y Raab; K Fredens; B Gerdin; R Hällgren
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

8.  Coeliac disease with histological features of peptic duodenitis: value of assessment of intraepithelial lymphocytes.

Authors:  M D Jeffers; D O Hourihane
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

9.  Abnormal leukotriene C4 released by unaffected jejunal mucosa in patients with inactive Crohn's disease.

Authors:  F Casellas; F Guarner; M Antolín; R Rodríguez; A Salas; J R Malagelada
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

10.  Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

Authors:  R Hällgren; B Gudbjörnsson; E Larsson; K Fredens
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.